The comparison of efficacy and safety of continuing olanzapine to switching to quetiapine in overweight or obese patients with schizophrenia and schizoaffective disorder
Phase of Trial: Phase IV
Latest Information Update: 18 Oct 2006
At a glance
- Drugs Olanzapine; Quetiapine
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 18 Oct 2006 The expected completion date for this trial is now .
- 27 Mar 2006 New trial record.